Home/Filings/4/0001193125-25-241381
4//SEC Filing

Lettmann Jason 4

Accession 0001193125-25-241381

CIK 0001810182other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:01 PM ET

Size

5.3 KB

Accession

0001193125-25-241381

Insider Transaction Report

Form 4
Period: 2025-10-14
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-10-14+597,500597,500 total
    Exercise: $1.70Exp: 2035-10-14Common Stock (597,500 underlying)
Footnotes (1)
  • [F1]One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026.

Documents

1 file

Issuer

ALX ONCOLOGY HOLDINGS INC

CIK 0001810182

Entity typeother

Related Parties

1
  • filerCIK 0001688269

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:01 PM ET
Size
5.3 KB